| Liesl Wenzke Hartmann, MA, CCC/SLP | |
|
672 2nd Ave, San Francisco, CA 94118-4008 | |
| (415) 310-6269 | |
| Not Available |
| Full Name | Liesl Wenzke Hartmann |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 672 2nd Ave, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003043217 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12920 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Liesl Wenzke Hartmann, MA, CCC/SLP 672 2nd Ave, San Francisco, CA 94118-4008 Ph: (415) 310-6269 | Liesl Wenzke Hartmann, MA, CCC/SLP 672 2nd Ave, San Francisco, CA 94118-4008 Ph: (415) 310-6269 |
News Archive
Delays in the launch and execution of critical market research projects can slow down the decision-making process, resulting in missed opportunities and increased costs. It is, therefore, absolutely critical for biopharmaceutical companies to develop a tactical approach to expedite the market research approval process for quicker and more meaningful insights.
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
A Ludwig Cancer Research study has uncovered a novel vulnerability in tumors that are driven by a common cancer gene known as MYC. Such cancers, it found, are highly dependent on the cell's machinery for making fats and other lipids.
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate.
› Verified 9 days ago
Maribel Serrano, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1023 Divisadero St, San Francisco, CA 94115 Phone: 415-226-7049 | |
Ms. Taylor Callaway, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 839 Post St Apt 206, San Francisco, CA 94109 Phone: 505-363-3559 | |
Ms. Patricia O'neill, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Portola Dr Ste 101, San Francisco, CA 94127 Phone: 415-722-7274 | |
Jacqueline Delgado, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 302 Silver Ave, San Francisco, CA 94112 Phone: 415-334-2500 | |
Jennifer Nasluchacz, MSR, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 180 Montgomery St, 20th Floor, San Francisco, CA 94104 Phone: 415-512-9000 | |
Jennifer Alicia Thaler, MS CCC- SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 Castro St, San Francisco, CA 94114 Phone: 415-600-6000 |